Simpson Thacher recently represented Teleflex Incorporated (NYSE: TFX) (“Teleflex”) in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 4.25% Senior Notes due 2028. Teleflex intends to use the net proceeds from the offering to repay borrowings under its revolving credit facility.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck®—trusted brands united by a common sense of purpose.
The Simpson Thacher team for this transaction included Roxane Reardon, Lia Toback, Clark Warthen and Deul Lim (Capital Markets); Jonathan Cantor (Tax); Michael Isby (Environmental); Jeanne Annarumma and Monisha Bhayana (Executive Compensation & Employee Benefits); and Lori Lesser, Alysha Sekhon and Bobbie Burrows (IP).